Alto Neuroscience, Inc. (ANRO) earnings
ANRO earnings moved a median of +5.78% by the close. Quarterly and annual ANRO reports and results, each read against the price at its own news timestamp. Back to the ANRO overview →
19 measured ANRO earnings events.
Where these ANRO earnings landedvs 19 measured ANRO earnings reactions
| Middle 50% of ANRO earnings reactions | -1.14% to +7.64% |
|---|---|
| Median reaction (to close) | +5.78% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 ANRO earnings events with a measured close landed between -1.14% and +7.64%; 68% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +4.77% | +7.67% | |
| Form 10-Q Alto Neuroscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | +4.77% | +7.67% | |
| Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | Press release | -1.11% | -4.35% | |
| Form 10-Q Alto Neuroscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.11% | -4.35% | |
| Form 10-K Alto Neuroscience, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.75% | +7.86% | |
| Alto Neuroscience Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Press release | +2.56% | +6.77% | |
| Form 10-Q Alto Neuroscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.56% | +6.77% | |
| Alto Neuroscience Reports Second Quarter 2025 Financial Results and Recent Business Highlights | Press release | -1.63% | +1.63% | |
| Form 10-Q Alto Neuroscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.63% | +1.63% | |
| Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights | Press release | -1.82% | +10.46% | |
| Form 10-Q Alto Neuroscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.82% | +10.46% | |
| Form 10-K Alto Neuroscience, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.85% | +0.76% | |
| Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | +1.51% | -1.95% | |
| Form 10-Q Alto Neuroscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.51% | -1.95% | |
| Alto Neuroscience Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | +0.00% | +5.78% | |
| Form 10-Q Alto Neuroscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +5.78% | |
| Alto Neuroscience Reports First Quarter 2024 Financial Results and Recent Business Highlights | Press release | +0.00% | -1.14% | |
| Form 10-Q Alto Neuroscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.14% | |
| Form 10-K Alto Neuroscience, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.74% | +7.62% |
Keep exploring
More ANRO: analyst actions → · SEC filings → · ANRO overview →